SCHEMBL23535552

SCHEMBL23535552

O=C(NCCCN1CCCC1=O)c1ccc(-c2nnc3cnc(-c4ccccc4)cn23)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 1/20 0.51
NAMPT P43490 2/20 0.49
USP2 O75604 1/20 0.48
RCE1 Q9Y256 1/20 0.47
MEN1 O00255 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 1/20 0.46
FSHR P23945 1/20 0.45
GABRA5 P31644 1/20 0.45
FYN P06241 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23535583 0.88 TSHR (0.53) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL23535543 0.88 ALDH1A1 (0.52) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL16495441 0.82 TSHR (0.66) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL23535565 0.81 TSHR (0.62) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL23535610 0.81 NPC1 (0.49) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL30015003 0.79 TYRO3 (0.47) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL23535482 0.79 TYRO3 (0.47) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL4707395 0.76 LMNA (0.75) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL16495989 0.76 GABRA5 (0.60) ALDH1A1TSHRSMN1; SMN2LMNANAMPT
SCHEMBL23535549 0.75 ATM (0.54) ALDH1A1SMN1; SMN2KDM4EFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768757-A CD206 modulators and uses and methods of making thereof 美利坚合众国,由健康及人类服务部部长代表 2023-03-07 CN disclosed
US-20230056497-A1 CD206 Modulators Their Use and Methods for Preparation US HEALTH (US) 2023-02-23 US disclosed
EP-4077297-A1 CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION The United States Of America, As Represented By The Secretary, Department Of Health And Human Services (US) 2022-10-26 EP disclosed
WO-2021126923-A1 CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2021-06-24 WO disclosed
WO-2021126923-A1 CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230056497-A1 CD206 Modulators Their Use and Methods for Preparation CD209, MSR1, ARG1 ALDH1A1 2010/4885TSHR 457/4885SMN1; SMN2 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.